Biostar Pharmaceuticals, Inc. Deferred Tax Assets, Net of Valuation Allowance, Noncurrent
Biostar Pharmaceuticals, Inc. had Deferred Tax Assets, Net of Valuation Allowance, Noncurrent of $2.63 million as of 2017-09-30, per its 10-Q filed 2017-11-20.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsNetNoncurrent · last filed 2017-11-20
- 2017-09-30: Deferred Tax Assets, Net of Valuation Allowance, Noncurrent $2.63M.
- 2017-06-30: Deferred Tax Assets, Net of Valuation Allowance, Noncurrent $2.57M.
- 2017-03-31: Deferred Tax Assets, Net of Valuation Allowance, Noncurrent $2.53M.
- 2016-12-31: Deferred Tax Assets, Net of Valuation Allowance, Noncurrent $2.52M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance, Noncurrent |
|---|---|
| 2017-09-30 | $2.63M 10-Q · filed 2017-11-20 |
| 2017-06-30 | $2.57M 10-Q · filed 2017-11-15 |
| 2017-03-31 | $2.53M 10-Q · filed 2017-05-19 |
| 2016-12-31 | $2.52M 10-Q · filed 2017-11-20 |
| 2016-09-30 | $5.26M 10-Q · filed 2016-11-21 |
| 2016-06-30 | $5.28M 10-Q · filed 2016-08-22 |
| 2016-03-31 | $5.44M 10-Q · filed 2016-05-23 |
| 2015-12-31 | $5.41M 10-K · filed 2017-04-13 |
| 2015-09-30 | $7.39M 10-Q · filed 2015-11-23 |
| 2015-06-30 | $7.78M 10-Q · filed 2015-08-19 |
| 2015-03-31 | $7.58M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $7.07M 10-K · filed 2016-04-14 |
| 2014-09-30 | $3.23M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $3.51M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $2.90M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $2.79M 10-K · filed 2015-04-15 |
| 2013-09-30 | $3.22M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $3.51M 10-Q · filed 2013-08-19 |
| 2013-03-31 | $3.33M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $3.67M 10-K · filed 2014-03-31 |
| 2012-09-30 | $3.33M 10-Q · filed 2012-11-19 |
| 2012-06-30 | $3.44M 10-Q · filed 2012-08-14 |
| 2012-03-31 | $1.11M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $1.62M 10-K · filed 2013-04-15 |